WYNETTE ALMEIDA: Open Payments
NPI 1518550268 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 13 payments from 12 companies in 2025. Trend: 2023 $652 · 2024 $615 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $179 |
| ABBVIE INC. | 1 | $116 |
| Janssen Biotech, Inc. | 1 | $46 |
| Gilead Sciences, Inc. | 1 | $31 |
| PFIZER INC. | 1 | $26 |
| Eisai Inc. | 1 | $23 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Ardelyx, Inc. | 1 | $22 |
Products named: Enhertu, TREMFYA, Trodelvy, PADCEV, Lenvima, NERLYNX, VOWST, Nubeqa.
Industry payments across NY — which companies pay providers there.
